MAR 04, 2016 07:00 AM PST

Low vitamin D predicts aggressive prostate cancer

Men who are deficient in vitamin D often have more aggressive prostate cancer at the time of surgery, according to a recent study.
 
"All men should be replenishing their vitamin D to normal levels," Adam Murphy says. "It's smart preventive health care."

While other studies have shown an association between vitamin D levels and aggressive prostate cancer, they were based on blood drawn well before treatment. The new study provides a more direct correlation because it measured D levels within a couple of months before the tumor was visually identified as aggressive during surgery to remove the prostate (radical prostatectomy).

The finding can offer guidance to men and their doctors who may be considering active surveillance, in which they monitor the cancer rather than remove the prostate.

“Men with dark skin, low vitamin D intake, or low sun exposure should be tested for vitamin D deficiency when they are diagnosed with an elevated PSA or prostate cancer. Then a deficiency should be corrected with supplements,” says Adam Murphy, an assistant professor of urology at Northwestern University and lead investigator.

The relationship between vitamin D and prostate cancer may explain some disparities seen in prostate cancer, especially among African-American men. Prior research by Murphy and colleagues showed African-American men who live in low sunlight locations are up to 1½ times more likely to have vitamin D deficiency than Caucasian men.

But because vitamin D is a biomarker for bone health and aggressiveness of other diseases, all men should check their levels, Murphy says.

“All men should be replenishing their vitamin D to normal levels,” Murphy adds. “It’s smart preventive health care.”

Aggressive prostate cancer is defined by whether the cancer has migrated outside of the prostate and by a high Gleason score. A low Gleason score means the cancer tissue is similar to normal prostate tissue and less likely to spread; a high one means the cancer tissue is very different from normal and more likely to spread.

The study was part of a larger ongoing study of 1,760 men in the Chicago area examining vitamin D and prostate cancer. The current study included 190 men, average age of 64, who underwent a radical prostatectomy to remove their prostate from 2009 to 2014.

Of that group, 87 men had aggressive prostate cancer. Those with aggressive cancer had a median level of 22.7 nanograms per milliliter of vitamin D, significantly below the normal level of more than 30 nanograms/milliliter. The average D level in Chicago during the winter is about 25 nanograms/milliliter, Murphy notes.

“It’s very hard to have normal levels when you work in an office every day and because of our long winter,” he says.

The study was published in the Journal of Clinical Oncology. Murphy collaborated on the study with Rick Kittles, associate director of cancer disparities at the University of Arizona Cancer Center.

The National Institutes of Health, the Veterans Health Administration, and the US Department of Defense funded the study.

Source: Northwestern University

This article was originally published on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
OCT 21, 2019
Cancer
OCT 21, 2019
More younger people diagnosed with colorectal cancer
According to the American Cancer Society (ACS), colorectal cancer is the third most commonly diagnosed cancer, not including skin cancers. Now new research...
OCT 21, 2019
Cancer
OCT 21, 2019
Cancer drugs don't work the way we thought
New research recently published in the journal Science Translational Medicine surprises the oncological community with findings that a protein previously t...
OCT 21, 2019
Genetics & Genomics
OCT 21, 2019
Breast Cancer Drug Increases Survival for Prostate Cancer Patients
A breast cancer drug is better at treating advanced prostate cancer in some men than current therapies, a clinical trial shows....
OCT 21, 2019
Drug Discovery & Development
OCT 21, 2019
Evolutionary-Busting Cancer Drug
Researchers at the Institute of Cancer Research in London have discovered that a new type of drug that blocks treatment in cancers. The drug works by inhib...
OCT 21, 2019
Cancer
OCT 21, 2019
Using temperature to awaken immune response to fight brain cancer
Glioblastoma is the most common form of adult brain cancer and also one of the most aggressive human cancers. Immunotherapy has yet to be shown proven effe...
OCT 21, 2019
Genetics & Genomics
OCT 21, 2019
A Cancer-Promoting Mutation is Found in 'Junk' DNA
A huge amount of our genome does not code for protein, but it can impact physiology in other ways....
Loading Comments...